Erratum: Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

Errata

This article corrects:

  1. Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma Volume 117, Issue 10, 2112–2119, Article first published online: 29 November 2010

No abstract is available for this article.

Ancillary